SLC2A1 and gastric cancer: Studies have shown that the overexpression of SLC2A1 in cervical cancer (Rudlowski et al., 2004), gastric cancer (Berlth et al., 2015), esophageal cancer (Kato et al., 2002), and oral cancer (Pereira et al., 2013) can advance the proliferation of cancer cells.